CAP AMP-led Expert Groups Release Clinical CYP2D6 Pharmacogenomic Testing Recommendation The consensus guideline offers a two-tier categorization of alleles that are recommended for clinical CYP2D6 pharmacogenetic testing. Cancer, Pathology Organizations Developing Clinical Guidelines for MMR, MSI Testing The groups have written draft recommendations and are now asking for public comment from pathologists and other stakeholders. Global Survey Reveals Suboptimal Molecular Testing Access in Lung Cancer Despite Broad Guidelines Premium An IASLC survey showed that molecular testing is not performed in line with expert guidelines, which means only a minority of lung cancer patients are benefitting from precision oncology. Harmonizing NGS Test Panels Remains a Challenge for Clinical Sequencing Premium As NGS testing becomes more widespread, labs, payors, and professional groups confront questions about which genes should be required as part of clinical assays. Pathologists Face Hurdles in Supporting Precision Oncology, Seek Shared Decision Making Premium Practical, technological, and systemic challenges are putting pathologists in tough positions, facing competing demands for molecular analysis of limited biological samples. Jun 21, 2019 AMP and CAP Comment on Palmetto Proposed Guidelines for NGS Testing of Myeloid Disorders Jun 22, 2018 In Brief This Week: Baby Genes, J&J Innovation, Myriad Genetics, Merck, More Jun 22, 2018 Some Stakeholders Not on Board With Draft Bill on New Dx Regulatory Framework Premium Mar 16, 2018 ASCO/CAP ctDNA Report Offers Check on Bold Commercial Claims, RoadMap for Proving Value Premium Mar 15, 2018 Industry Groups Lobby Congress Ahead of Final CMS National Coverage Policy on NGS Cancer Panels Premium Nov 16, 2017 AMP-Led Workgroup Publishes Guidelines for Validating NGS Bioinformatics Pipelines Oct 16, 2017 CAP Launches Proficiency Testing Program for NIPT, Using Maternal Plasma Samples Premium Oct 6, 2017 Lab Industry Reacts to USPSTF Recommendation Against Cervical Cancer Co-testing May 1, 2017 BRAF Proficiency Testing Reporting Adequate But Could Improve, Analysis Finds Mar 22, 2017 AMP, CAP Publish Validation Guidelines for NGS-Based Oncology Panels Mar 21, 2017 Cofactor Genomics Launches First RNA-Seq Clinical Assay Premium Feb 6, 2017 Societies Release Clinical Practice Guidelines for Colorectal Cancer Molecular Testing Dec 16, 2016 New Guidelines Aim to Standardize Interpretation and Reporting of Somatic Cancer Variants Premium Dec 6, 2016 Eurofins Genomics Kentucky Lab Gets CLIA, CAP Accreditation Nov 17, 2016 At AMP Meeting, Pathologists Discuss Challenges of Implementing ACMG Variant Classification Guidelines Premium Nov 14, 2016 Oncologists, Pathologists Issue HER2 Testing Guidance for Gastroesophageal Cancer Patients Jul 1, 2016 In Brief This Week: CAP, IASLC, AMP; Cancer Genetics; Charles River Laboratories; Enzo Biochem Jun 16, 2016 New Quality Assessment Scheme Seeks to Improve Next-Gen Sequencing In Diagnostic Labs Premium Apr 19, 2016 NantOmics Earns CLIA Certification, CAP Accreditation Mar 28, 2016 State Lab Overseer NYSDOH Issues Plan for LDT Pre-Market Approval Premium Load More Breaking News Alzheimer's Disease Phosphoproteomics Study Uncovers Signaling Abnormalities Genetic Analysis of H. Pylori Indicates Americas Colonized in One Main Migration Event BillionToOne Raises $55M in Series B Financing GeninCode to Launch Cardiovascular Disease Risk Tests in US With Eversana Top Five Articles on GenomeWeb Last Week: Illumina, Liquid Biopsy, Thermo Fisher Scientific, and More Becton Dickinson Sues Beckman Coulter Over Cell Analysis, Sorting IP The Scan Another Resignation According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug. Novavax Finds Its Vaccine Effective Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19. Can't Be Used The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports. PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.